| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥37.17 |
| 52 Week High | CN¥38.03 |
| 52 Week Low | CN¥30.56 |
| Beta | 0.031 |
| 1 Month Change | 8.37% |
| 3 Month Change | 14.40% |
| 1 Year Change | 17.78% |
| 3 Year Change | 16.89% |
| 5 Year Change | 66.98% |
| Change since IPO | 67.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2223 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -0.3% | 5.2% | 2.2% |
| 1Y | 17.8% | -16.8% | -14.2% |
Return vs Industry: 002223 exceeded the CN Medical Equipment industry which returned -16.8% over the past year.
Return vs Market: 002223 exceeded the CN Market which returned -14.2% over the past year.
Price Volatility
| 2223 volatility | |
|---|---|
| 2223 Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002223 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002223's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 6,114 | Qun Wu | www.yuyue.com.cn |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages in the manufacture and sale of medical devices in China and internationally. The company offers respiratory solutions, including single and bi-level PAP, breathwear masks, oxygen concentrators, high flow nasal cannula oxygen therapy, nebulizers, and suction apparatus; blood pressure and glucose systems; infrared, infrared ear, and medical digital thermometers; oximeters; and wheelchairs and electric wheelchairs.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Fundamentals Summary
| 2223 fundamental statistics | |
|---|---|
| Market cap | CN¥37.24b |
| Earnings (TTM) | CN¥2.34b |
| Revenue (TTM) | CN¥7.50b |
15.9x
P/E Ratio5.0x
P/S RatioIs 2223 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2223 income statement (TTM) | |
|---|---|
| Revenue | CN¥7.50b |
| Cost of Revenue | CN¥3.74b |
| Gross Profit | CN¥3.76b |
| Other Expenses | CN¥1.41b |
| Earnings | CN¥2.34b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.34 |
| Gross Margin | 50.07% |
| Net Profit Margin | 31.22% |
| Debt/Equity Ratio | 8.0% |
How did 2223 perform over the long term?
See historical performance and comparison